{"id":2888,"date":"2018-02-16T16:33:44","date_gmt":"2018-02-16T16:33:44","guid":{"rendered":"http:\/\/www.sarmsthailand.com\/?p=2888"},"modified":"2019-09-11T12:19:47","modified_gmt":"2019-09-11T12:19:47","slug":"lgd-4033-ligandrol","status":"publish","type":"post","link":"https:\/\/www.sarmsthailand.com\/th\/uncategorized\/lgd-4033-ligandrol\/","title":{"rendered":"LGD 4033 (Ligandrol)"},"content":{"rendered":"<div class=\"single-featured\"><a href=\"http:\/\/www.sarmsthailand.com\/wp-content\/uploads\/2018\/02\/LGD-4033.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone size-full wp-image-3012\" src=\"http:\/\/www.sarmsthailand.com\/wp-content\/uploads\/2018\/02\/LGD-4033.png\" alt=\"\" width=\"750\" height=\"400\" srcset=\"https:\/\/www.sarmsthailand.com\/wp-content\/uploads\/2018\/02\/LGD-4033.png 750w, https:\/\/www.sarmsthailand.com\/wp-content\/uploads\/2018\/02\/LGD-4033-600x320.png 600w, https:\/\/www.sarmsthailand.com\/wp-content\/uploads\/2018\/02\/LGD-4033-300x160.png 300w\" sizes=\"(max-width: 750px) 100vw, 750px\" \/><\/a><a class=\"post-thumbnail open-lightbox\" href=\"http:\/\/www.sarmstore1.com\/wp-content\/uploads\/2015\/08\/LGD-4033.png\"><br \/>\n<\/a><\/div>\n<div class=\"post-header-inner\">\n<div class=\"post-header-title\">\n<div class=\"term-badges floated\"><span class=\"term-badge term-201\">\u00a0<\/span><\/div>\n<h1 class=\"single-post-title\"><span class=\"post-title\">LGD 4033 (Ligandrol)<\/span><\/h1>\n<div class=\"post-meta single-post-meta\"><span class=\"time\"><time class=\"post-published updated\" datetime=\"2018-01-09T18:54:12+00:00\">\u0e2d\u0e31\u0e1b\u0e40\u0e14\u0e15\u0e25\u0e48\u0e32\u0e2a\u0e38\u0e14 <strong>May 12, 2018<\/strong><\/time><\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"entry-content clearfix single-post-content\">\n<p dir=\"LTR\" align=\"LEFT\">\u0e21\u0e31\u0e19\u0e16\u0e39\u0e01\u0e08\u0e31\u0e14\u0e2d\u0e22\u0e39\u0e48\u0e43\u0e19\u0e1b\u0e23\u0e30\u0e40\u0e20\u0e17\u0e02\u0e2d\u0e07\u0e15\u0e31\u0e27\u0e23\u0e31\u0e1a\u0e2e\u0e2d\u0e23\u0e4c\u0e42\u0e21\u0e19\u0e41\u0e2d\u0e19\u0e42\u0e14\u0e23\u0e40\u0e08\u0e19(AR) \u0e0b\u0e36\u0e48\u0e07\u0e40\u0e1b\u0e47\u0e19\u0e2a\u0e32\u0e23\u0e1b\u0e23\u0e30\u0e01\u0e2d\u0e1a\u0e40\u0e0a\u0e34\u0e07\u0e0b\u0e49\u0e2d\u0e19\u0e17\u0e35\u0e48\u0e21\u0e35\u0e01\u0e32\u0e23\u0e04\u0e31\u0e14\u0e2a\u0e23\u0e23\u0e1e\u0e31\u0e12\u0e19\u0e32\u0e40\u0e1e\u0e37\u0e48\u0e2d\u0e23\u0e31\u0e01\u0e29\u0e32\u0e2d\u0e32\u0e01\u0e32\u0e23\u0e2a\u0e39\u0e0d\u0e40\u0e2a\u0e35\u0e22\u0e01\u0e25\u0e49\u0e32\u0e21\u0e40\u0e19\u0e37\u0e49\u0e2d\u0e17\u0e35\u0e48\u0e40\u0e01\u0e35\u0e48\u0e22\u0e27\u0e02\u0e49\u0e2d\u0e07\u0e01\u0e31\u0e1a\u0e42\u0e23\u0e04\u0e21\u0e30\u0e40\u0e23\u0e47\u0e07, \u0e04\u0e27\u0e32\u0e21\u0e40\u0e08\u0e47\u0e1a\u0e1b\u0e48\u0e27\u0e22\u0e40\u0e09\u0e35\u0e22\u0e1a\u0e1e\u0e25\u0e31\u0e19\u0e41\u0e25\u0e30\u0e40\u0e23\u0e37\u0e49\u0e2d\u0e23\u0e31\u0e07, \u0e41\u0e25\u0e30\u0e01\u0e32\u0e23\u0e2a\u0e39\u0e0d\u0e40\u0e2a\u0e35\u0e22\u0e01\u0e25\u0e49\u0e32\u0e21\u0e40\u0e19\u0e37\u0e49\u0e2d\u0e40\u0e19\u0e37\u0e48\u0e2d\u0e07\u0e08\u0e32\u0e01\u0e2d\u0e32\u0e22\u0e38\u0e17\u0e35\u0e48\u0e21\u0e32\u0e01\u0e02\u0e36\u0e49\u0e19LGD-4033 \u0e04\u0e32\u0e14\u0e27\u0e48\u0e32\u0e08\u0e30\u0e43\u0e2b\u0e49\u0e1c\u0e25\u0e17\u0e35\u0e48\u0e40\u0e1b\u0e47\u0e19\u0e1b\u0e23\u0e30\u0e42\u0e22\u0e0a\u0e19\u0e4c\u0e14\u0e49\u0e32\u0e19\u0e01\u0e32\u0e23\u0e1a\u0e32\u0e1a\u0e31\u0e14\u0e23\u0e31\u0e01\u0e29\u0e32\u0e17\u0e35\u0e48\u0e40\u0e01\u0e35\u0e48\u0e22\u0e27\u0e01\u0e31\u0e1a\u0e2e\u0e2d\u0e23\u0e4c\u0e42\u0e21\u0e19\u0e40\u0e1e\u0e28\u0e0a\u0e32\u0e22\u0e42\u0e14\u0e22\u0e21\u0e35\u0e04\u0e27\u0e32\u0e21\u0e1b\u0e25\u0e2d\u0e14\u0e20\u0e31\u0e22, \u0e04\u0e07\u0e17\u0e19\u0e41\u0e25\u0e30\u0e40\u0e1b\u0e47\u0e19\u0e17\u0e35\u0e48\u0e22\u0e2d\u0e21\u0e23\u0e31\u0e1a\u0e08\u0e32\u0e01\u0e1c\u0e39\u0e49\u0e1b\u0e48\u0e27\u0e22\u0e40\u0e19\u0e37\u0e48\u0e2d\u0e07\u0e08\u0e32\u0e01\u0e01\u0e25\u0e44\u0e01\u0e01\u0e32\u0e23\u0e40\u0e1e\u0e32\u0e30\u0e40\u0e25\u0e35\u0e49\u0e22\u0e07\u0e40\u0e19\u0e37\u0e49\u0e2d\u0e40\u0e22\u0e37\u0e48\u0e2d\u0e17\u0e35\u0e48\u0e44\u0e14\u0e49\u0e23\u0e31\u0e1a\u0e01\u0e32\u0e23\u0e04\u0e31\u0e14\u0e40\u0e25\u0e37\u0e2d\u0e01\u0e41\u0e25\u0e30\u0e21\u0e35\u0e01\u0e32\u0e23\u0e1e\u0e31\u0e12\u0e19\u0e32\u0e17\u0e14\u0e25\u0e2d\u0e07\u0e43\u0e0a\u0e49\u0e01\u0e31\u0e1a\u0e40\u0e19\u0e37\u0e49\u0e2d\u0e40\u0e22\u0e37\u0e48\u0e2d\u0e23\u0e30\u0e1a\u0e1a\u0e17\u0e32\u0e07\u0e40\u0e14\u0e34\u0e19\u0e2d\u0e32\u0e2b\u0e32\u0e23<\/p>\n<p dir=\"LTR\" align=\"LEFT\">LGD \u0e41\u0e2a\u0e14\u0e07\u0e43\u0e2b\u0e49\u0e40\u0e2b\u0e47\u0e19\u0e16\u0e36\u0e07\u0e04\u0e27\u0e32\u0e21\u0e2a\u0e32\u0e21\u0e32\u0e23\u0e16\u0e2a\u0e39\u0e07\u0e2a\u0e38\u0e14\u0e02\u0e2d\u0e07SARM \u0e17\u0e35\u0e48\u0e08\u0e30\u0e19\u0e32\u0e21\u0e32\u0e43\u0e0a\u0e49\u0e43\u0e19\u0e02\u0e19\u0e32\u0e14\u0e02\u0e2d\u0e07\u0e1a\u0e38\u0e04\u0e04\u0e25\u0e17\u0e35\u0e48\u0e08\u0e30\u0e25\u0e14\u0e19\u0e49\u0e32\u0e2b\u0e19\u0e31\u0e01\u0e0b\u0e36\u0e48\u0e07\u0e40\u0e1b\u0e47\u0e19\u0e25\u0e31\u0e01\u0e29\u0e13\u0e30\u0e17\u0e35\u0e48\u0e40\u0e23\u0e48\u0e07\u0e01\u0e32\u0e23\u0e25\u0e14\u0e19\u0e49\u0e32\u0e2b\u0e19\u0e31\u0e01\u0e43\u0e19\u0e23\u0e30\u0e14\u0e31\u0e1a\u0e02\u0e19\u0e32\u0e14\u0e19\u0e49\u0e32\u0e2b\u0e19\u0e31\u0e01\u0e21\u0e32\u0e01\u0e0b\u0e36\u0e48\u0e07\u0e41\u0e19\u0e48\u0e19\u0e2d\u0e19\u0e08\u0e30\u0e02\u0e36\u0e49\u0e19\u0e2d\u0e22\u0e39\u0e48\u0e01\u0e31\u0e1a\u0e27\u0e34\u0e18\u0e35\u0e01\u0e32\u0e23\u0e17\u0e35\u0e48\u0e43\u0e0a\u0e49\u0e43\u0e19\u0e01\u0e32\u0e23\u0e25\u0e14\u0e19\u0e49\u0e32\u0e2b\u0e19\u0e31\u0e01\u0e1c\u0e39\u0e49\u0e43\u0e0a\u0e49\u0e17\u0e35\u0e48\u0e21\u0e35\u0e1b\u0e23\u0e30\u0e2a\u0e1a\u0e01\u0e32\u0e23\u0e13\u0e4c\u0e17\u0e35\u0e48\u0e19\u0e49\u0e32\u0e2b\u0e19\u0e31\u0e01\u0e40\u0e1e\u0e34\u0e48\u0e21\u0e02\u0e36\u0e49\u0e19\u0e21\u0e32\u0e01\u0e01\u0e27\u0e48\u0e3210 \u0e1b\u0e2d\u0e19\u0e14\u0e4c\u0e41\u0e25\u0e30\u0e21\u0e35\u0e01\u0e32\u0e23\u0e40\u0e1e\u0e34\u0e48\u0e21\u0e02\u0e36\u0e49\u0e19\u0e2d\u0e22\u0e48\u0e32\u0e07\u0e21\u0e32\u0e01\u0e02\u0e2d\u0e07\u0e1b\u0e23\u0e34\u0e21\u0e32\u0e13\u0e41\u0e04\u0e25\u0e2d\u0e23\u0e35\u0e48. \u0e04\u0e27\u0e32\u0e21\u0e40\u0e1b\u0e47\u0e19\u0e44\u0e1b\u0e44\u0e14\u0e49\u0e2a\u0e32\u0e2b\u0e23\u0e31\u0e1a\u0e23\u0e30\u0e14\u0e31\u0e1a\u0e19\u0e35\u0e49\u0e08\u0e30\u0e44\u0e14\u0e49\u0e1c\u0e25\u0e40\u0e21\u0e37\u0e48\u0e2d\u0e43\u0e0a\u0e49LGD \u0e1b\u0e23\u0e34\u0e21\u0e32\u0e13\u0e17\u0e35\u0e48\u0e41\u0e19\u0e30\u0e19\u0e32\u0e2a\u0e32\u0e2b\u0e23\u0e31\u0e1a\u0e40\u0e1b\u0e49\u0e32\u0e2b\u0e21\u0e32\u0e22\u0e1b\u0e23\u0e30\u0e40\u0e20\u0e17\u0e19\u0e35\u0e49\u0e04\u0e37\u0e2d5-10 \u0e21\u0e01. \u0e15\u0e48\u0e2d\u0e27\u0e31\u0e19\u0e40\u0e1b\u0e47\u0e19\u0e40\u0e27\u0e25\u0e328 \u0e2a\u0e31\u0e1b\u0e14\u0e32\u0e2b\u0e4c<\/p>\n<ul>\n<li dir=\"LTR\">\u0e1c\u0e25\u0e17\u0e35\u0e48\u0e44\u0e14\u0e49\u0e40\u0e21\u0e37\u0e48\u0e2d\u0e40\u0e17\u0e35\u0e22\u0e1a\u0e01\u0e31\u0e1a\u0e2d\u0e19\u0e32\u0e42\u0e1a\u0e25\u0e34\u0e01\u0e43\u0e19\u0e14\u0e49\u0e32\u0e19\u0e02\u0e19\u0e32\u0e14\u0e41\u0e25\u0e30\u0e04\u0e27\u0e32\u0e21\u0e41\u0e02\u0e47\u0e07\u0e41\u0e23\u0e07\u0e17\u0e35\u0e48\u0e04\u0e25\u0e49\u0e32\u0e22\u0e01\u0e31\u0e19<\/li>\n<li dir=\"LTR\">\u0e1c\u0e25\u0e02\u0e49\u0e32\u0e07\u0e40\u0e04\u0e35\u0e22\u0e07\u0e21\u0e35\u0e19\u0e49\u0e2d\u0e22\u0e17\u0e35\u0e48\u0e2a\u0e38\u0e14<\/li>\n<li dir=\"LTR\">\u0e44\u0e14\u0e49\u0e1c\u0e25\u0e40\u0e1b\u0e47\u0e19\u0e40\u0e25\u0e34\u0e28\u0e2a\u0e32\u0e2b\u0e23\u0e31\u0e1a\u0e01\u0e32\u0e23\u0e1f\u0e37\u0e49\u0e19\u0e1f\u0e39\u0e2a\u0e20\u0e32\u0e1e<\/li>\n<li dir=\"LTR\">\u0e21\u0e35\u0e04\u0e38\u0e13\u0e2a\u0e21\u0e1a\u0e31\u0e15\u0e34\u0e14\u0e49\u0e32\u0e19\u0e01\u0e32\u0e23\u0e23\u0e31\u0e01\u0e29\u0e32\u0e1a\u0e32\u0e1a\u0e31\u0e14<\/li>\n<li dir=\"LTR\">\u0e1b\u0e49\u0e2d\u0e07\u0e01\u0e31\u0e19\u0e01\u0e32\u0e23\u0e2a\u0e39\u0e0d\u0e40\u0e2a\u0e35\u0e22\u0e01\u0e25\u0e49\u0e32\u0e21\u0e40\u0e19\u0e37\u0e49\u0e2d<\/li>\n<li dir=\"LTR\">\u0e17\u0e32\u0e07\u0e32\u0e19\u0e44\u0e14\u0e49\u0e14\u0e35\u0e43\u0e19\u0e23\u0e39\u0e1b\u0e41\u0e1a\u0e1a\u0e40\u0e14\u0e35\u0e48\u0e22\u0e27\u0e2b\u0e23\u0e37\u0e2d\u0e23\u0e48\u0e27\u0e21\u0e01\u0e31\u0e19\u0e01\u0e31\u0e1aSARMS \u0e2d\u0e37\u0e48\u0e19\u0e46<\/li>\n<li dir=\"LTR\">\u0e44\u0e14\u0e49\u0e1c\u0e25\u0e25\u0e31\u0e1e\u0e18\u0e4c\u0e17\u0e35\u0e48\u0e22\u0e2d\u0e14\u0e40\u0e22\u0e35\u0e48\u0e22\u0e21\u0e43\u0e19\u0e17\u0e38\u0e01\u0e41\u0e07\u0e48\u0e21\u0e38\u0e21\u0e2a\u0e32\u0e2b\u0e23\u0e31\u0e1a\u0e40\u0e1b\u0e49\u0e32\u0e2b\u0e21\u0e32\u0e22\u0e1b\u0e23\u0e30\u0e40\u0e20\u0e17\u0e15\u0e48\u0e32\u0e07\u0e46<\/li>\n<li dir=\"LTR\">\u0e43\u0e2b\u0e49\u0e1c\u0e25\u0e40\u0e1b\u0e47\u0e19\u0e23\u0e30\u0e22\u0e30\u0e40\u0e27\u0e25\u0e3224-36 \u0e0a\u0e31\u0e48\u0e27\u0e42\u0e21\u0e07<\/li>\n<\/ul>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>\u00a0 LGD 4033 (Ligandrol) Last updated May 12, 2018 It&#8217;s in a class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2888","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>What is Ligandrol LGD-4033 Sarm? | Sarms Thailand<\/title>\n<meta name=\"description\" content=\"It&#039;s in a class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sarmsthailand.com\/th\/uncategorized\/lgd-4033-ligandrol\/\" \/>\n<meta property=\"og:locale\" content=\"th_TH\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What is Ligandrol LGD-4033 Sarm? | Sarms Thailand\" \/>\n<meta property=\"og:description\" content=\"It&#039;s in a class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sarmsthailand.com\/th\/uncategorized\/lgd-4033-ligandrol\/\" \/>\n<meta property=\"og:site_name\" content=\"Sarms Thailand\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/sarmsthailand\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-02-16T16:33:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-09-11T12:19:47+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.sarmsthailand.com\/wp-content\/uploads\/2018\/02\/LGD-4033.png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u0e19\u0e32\u0e17\u0e35\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/www.sarmsthailand.com\/#\/schema\/person\/e75ab74739d246ac8077558e2a7b8de7\"},\"headline\":\"LGD 4033 (Ligandrol)\",\"datePublished\":\"2018-02-16T16:33:44+00:00\",\"dateModified\":\"2019-09-11T12:19:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/\"},\"wordCount\":184,\"publisher\":{\"@id\":\"https:\/\/www.sarmsthailand.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/www.sarmsthailand.com\/wp-content\/uploads\/2018\/02\/LGD-4033.png\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"th\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/\",\"url\":\"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/\",\"name\":\"What is Ligandrol LGD-4033 Sarm? | Sarms Thailand\",\"isPartOf\":{\"@id\":\"https:\/\/www.sarmsthailand.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/www.sarmsthailand.com\/wp-content\/uploads\/2018\/02\/LGD-4033.png\",\"datePublished\":\"2018-02-16T16:33:44+00:00\",\"dateModified\":\"2019-09-11T12:19:47+00:00\",\"description\":\"It's in a class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/#breadcrumb\"},\"inLanguage\":\"th\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"th\",\"@id\":\"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/#primaryimage\",\"url\":\"http:\/\/www.sarmsthailand.com\/wp-content\/uploads\/2018\/02\/LGD-4033.png\",\"contentUrl\":\"http:\/\/www.sarmsthailand.com\/wp-content\/uploads\/2018\/02\/LGD-4033.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.sarmsthailand.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LGD 4033 (Ligandrol)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sarmsthailand.com\/#website\",\"url\":\"https:\/\/www.sarmsthailand.com\/\",\"name\":\"Sarms Thailand\",\"description\":\"Providing advanced manufactured Sarms in Thailand\",\"publisher\":{\"@id\":\"https:\/\/www.sarmsthailand.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sarmsthailand.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"th\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.sarmsthailand.com\/#organization\",\"name\":\"Sarms Thailand\",\"url\":\"https:\/\/www.sarmsthailand.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"th\",\"@id\":\"https:\/\/www.sarmsthailand.com\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/www.sarmsthailand.com\/wp-content\/uploads\/2019\/09\/3.jpg\",\"contentUrl\":\"http:\/\/www.sarmsthailand.com\/wp-content\/uploads\/2019\/09\/3.jpg\",\"width\":298,\"height\":298,\"caption\":\"Sarms Thailand\"},\"image\":{\"@id\":\"https:\/\/www.sarmsthailand.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/sarmsthailand\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.sarmsthailand.com\/#\/schema\/person\/e75ab74739d246ac8077558e2a7b8de7\",\"name\":\"admin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ligandrol LGD-4033 Sarm \u0e04\u0e37\u0e2d\u0e2d\u0e30\u0e44\u0e23 | Sarms \u0e1b\u0e23\u0e30\u0e40\u0e17\u0e28\u0e44\u0e17\u0e22","description":"It's in a class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sarmsthailand.com\/th\/uncategorized\/lgd-4033-ligandrol\/","og_locale":"th_TH","og_type":"article","og_title":"What is Ligandrol LGD-4033 Sarm? | Sarms Thailand","og_description":"It's in a class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration.","og_url":"https:\/\/www.sarmsthailand.com\/th\/uncategorized\/lgd-4033-ligandrol\/","og_site_name":"Sarms Thailand","article_publisher":"https:\/\/www.facebook.com\/sarmsthailand\/","article_published_time":"2018-02-16T16:33:44+00:00","article_modified_time":"2019-09-11T12:19:47+00:00","og_image":[{"url":"http:\/\/www.sarmsthailand.com\/wp-content\/uploads\/2018\/02\/LGD-4033.png","type":"","width":"","height":""}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 \u0e19\u0e32\u0e17\u0e35"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/#article","isPartOf":{"@id":"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/"},"author":{"name":"admin","@id":"https:\/\/www.sarmsthailand.com\/#\/schema\/person\/e75ab74739d246ac8077558e2a7b8de7"},"headline":"LGD 4033 (Ligandrol)","datePublished":"2018-02-16T16:33:44+00:00","dateModified":"2019-09-11T12:19:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/"},"wordCount":184,"publisher":{"@id":"https:\/\/www.sarmsthailand.com\/#organization"},"image":{"@id":"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/#primaryimage"},"thumbnailUrl":"http:\/\/www.sarmsthailand.com\/wp-content\/uploads\/2018\/02\/LGD-4033.png","articleSection":["Uncategorized"],"inLanguage":"th"},{"@type":"WebPage","@id":"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/","url":"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/","name":"Ligandrol LGD-4033 Sarm \u0e04\u0e37\u0e2d\u0e2d\u0e30\u0e44\u0e23 | Sarms \u0e1b\u0e23\u0e30\u0e40\u0e17\u0e28\u0e44\u0e17\u0e22","isPartOf":{"@id":"https:\/\/www.sarmsthailand.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/#primaryimage"},"image":{"@id":"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/#primaryimage"},"thumbnailUrl":"http:\/\/www.sarmsthailand.com\/wp-content\/uploads\/2018\/02\/LGD-4033.png","datePublished":"2018-02-16T16:33:44+00:00","dateModified":"2019-09-11T12:19:47+00:00","description":"It's in a class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration.","breadcrumb":{"@id":"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/#breadcrumb"},"inLanguage":"th","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/"]}]},{"@type":"ImageObject","inLanguage":"th","@id":"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/#primaryimage","url":"http:\/\/www.sarmsthailand.com\/wp-content\/uploads\/2018\/02\/LGD-4033.png","contentUrl":"http:\/\/www.sarmsthailand.com\/wp-content\/uploads\/2018\/02\/LGD-4033.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.sarmsthailand.com\/uncategorized\/lgd-4033-ligandrol\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sarmsthailand.com\/"},{"@type":"ListItem","position":2,"name":"LGD 4033 (Ligandrol)"}]},{"@type":"WebSite","@id":"https:\/\/www.sarmsthailand.com\/#website","url":"https:\/\/www.sarmsthailand.com\/","name":"Sarms Thailand","description":"Providing advanced manufactured Sarms in Thailand","publisher":{"@id":"https:\/\/www.sarmsthailand.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sarmsthailand.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"th"},{"@type":"Organization","@id":"https:\/\/www.sarmsthailand.com\/#organization","name":"Sarms Thailand","url":"https:\/\/www.sarmsthailand.com\/","logo":{"@type":"ImageObject","inLanguage":"th","@id":"https:\/\/www.sarmsthailand.com\/#\/schema\/logo\/image\/","url":"http:\/\/www.sarmsthailand.com\/wp-content\/uploads\/2019\/09\/3.jpg","contentUrl":"http:\/\/www.sarmsthailand.com\/wp-content\/uploads\/2019\/09\/3.jpg","width":298,"height":298,"caption":"Sarms Thailand"},"image":{"@id":"https:\/\/www.sarmsthailand.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/sarmsthailand\/"]},{"@type":"Person","@id":"https:\/\/www.sarmsthailand.com\/#\/schema\/person\/e75ab74739d246ac8077558e2a7b8de7","name":"admin"}]}},"_links":{"self":[{"href":"https:\/\/www.sarmsthailand.com\/th\/wp-json\/wp\/v2\/posts\/2888","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sarmsthailand.com\/th\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sarmsthailand.com\/th\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sarmsthailand.com\/th\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sarmsthailand.com\/th\/wp-json\/wp\/v2\/comments?post=2888"}],"version-history":[{"count":8,"href":"https:\/\/www.sarmsthailand.com\/th\/wp-json\/wp\/v2\/posts\/2888\/revisions"}],"predecessor-version":[{"id":3594,"href":"https:\/\/www.sarmsthailand.com\/th\/wp-json\/wp\/v2\/posts\/2888\/revisions\/3594"}],"wp:attachment":[{"href":"https:\/\/www.sarmsthailand.com\/th\/wp-json\/wp\/v2\/media?parent=2888"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sarmsthailand.com\/th\/wp-json\/wp\/v2\/categories?post=2888"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sarmsthailand.com\/th\/wp-json\/wp\/v2\/tags?post=2888"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}